Safety Study of Soluble Ferric Pyrophosphate (SFP) in Dialysate in CKD Patients Receiving Chronic Hemodialysis
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 718 participants.
Also called NCT01503021
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; triple masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 718 participants
- Registry
-
NCT01503021
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States, Canada
- Registry status
- Completed
Technical summary
Registry record NCT01503021. Randomized; triple masking; primary purpose treatment. Start 2011-11 (registry gives no type); primary completion 2014-01 (actual). Results posted on 2015-04-21.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Safety Study of Soluble Ferric Pyrophosphate (SFP) in Dialysate in CKD Patients Receiving Chronic Hemodialysis
- Condition
- End Stage Renal Disease
- Condition
- Chronic Kidney Disease
- Intervention (Drug)
- SFP
- Intervention (Other)
- Placebo
- Lead sponsor
- Rockwell Medical Technologies, Inc.
Record details
- Record id
cardio:ct-nct01503021- Content hash
5171c7daf983d48215efe25fd08dece26610a6f1f8899ff7ff414b15dd67be1a